Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1975 1
1977 1
1978 1
1983 1
2001 1
2004 1
2007 2
2008 5
2009 1
2010 1
2011 1
2012 1
2013 2
2015 3
2017 10
2018 7
2019 4
2020 4
2021 6
2022 11
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis.
Biermann J, Melms JC, Amin AD, Wang Y, Caprio LA, Karz A, Tagore S, Barrera I, Ibarra-Arellano MA, Andreatta M, Fullerton BT, Gretarsson KH, Sahu V, Mangipudy VS, Nguyen TTT, Nair A, Rogava M, Ho P, Koch PD, Banu M, Humala N, Mahajan A, Walsh ZH, Shah SB, Vaccaro DH, Caldwell B, Mu M, Wünnemann F, Chazotte M, Berhe S, Luoma AM, Driver J, Ingham M, Khan SA, Rapisuwon S, Slingluff CL Jr, Eigentler T, Röcken M, Carvajal R, Atkins MB, Davies MA, Agustinus A, Bakhoum SF, Azizi E, Siegelin M, Lu C, Carmona SJ, Hibshoosh H, Ribas A, Canoll P, Bruce JN, Bi WL, Agrawal P, Schapiro D, Hernando E, Macosko EZ, Chen F, Schwartz GK, Izar B. Biermann J, et al. Among authors: ingham m. Cell. 2022 Jul 7;185(14):2591-2608.e30. doi: 10.1016/j.cell.2022.06.007. Cell. 2022. PMID: 35803246 Free PMC article.
Multiplexed single-cell analysis reveals prognostic and nonprognostic T cell types in human colorectal cancer.
Masuda K, Kornberg A, Miller J, Lin S, Suek N, Botella T, Secener KA, Bacarella AM, Cheng L, Ingham M, Rosario V, Al-Mazrou AM, Lee-Kong SA, Kiran RP, Stoeckius M, Smibert P, Del Portillo A, Oberstein PE, Sims PA, Yan KS, Han A. Masuda K, et al. Among authors: ingham m. JCI Insight. 2022 Apr 8;7(7):e154646. doi: 10.1172/jci.insight.154646. JCI Insight. 2022. PMID: 35192548 Free PMC article.
Therapeutic advances in leiomyosarcoma.
Lacuna K, Bose S, Ingham M, Schwartz G. Lacuna K, et al. Among authors: ingham m. Front Oncol. 2023 Mar 8;13:1149106. doi: 10.3389/fonc.2023.1149106. eCollection 2023. Front Oncol. 2023. PMID: 36969049 Free PMC article. Review.
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas.
Meric-Bernstam F, Sweis RF, Hodi FS, Messersmith WA, Andtbacka RHI, Ingham M, Lewis N, Chen X, Pelletier M, Chen X, Wu J, McWhirter SM, Müller T, Nair N, Luke JJ. Meric-Bernstam F, et al. Among authors: ingham m. Clin Cancer Res. 2022 Feb 15;28(4):677-688. doi: 10.1158/1078-0432.CCR-21-1963. Clin Cancer Res. 2022. PMID: 34716197 Clinical Trial.
Editorial: New therapeutics for soft tissue sarcomas.
Weetall M, Rance M, Ingham M, Van Tine BA. Weetall M, et al. Among authors: ingham m. Front Oncol. 2023 Oct 16;13:1297215. doi: 10.3389/fonc.2023.1297215. eCollection 2023. Front Oncol. 2023. PMID: 37909024 Free PMC article. No abstract available.
Prostate cancer in transgender women.
Ingham MD, Lee RJ, MacDermed D, Olumi AF. Ingham MD, et al. Urol Oncol. 2018 Dec;36(12):518-525. doi: 10.1016/j.urolonc.2018.09.011. Epub 2018 Oct 12. Urol Oncol. 2018. PMID: 30322726 Review.
Cell-Cycle Therapeutics Come of Age.
Ingham M, Schwartz GK. Ingham M, et al. J Clin Oncol. 2017 Sep 1;35(25):2949-2959. doi: 10.1200/JCO.2016.69.0032. Epub 2017 Jun 3. J Clin Oncol. 2017. PMID: 28580868 Free PMC article. Review.
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).
Ingham M, Allred JB, Chen L, Das B, Kochupurakkal B, Gano K, George S, Attia S, Burgess MA, Seetharam M, Boikos SA, Bui N, Chen JL, Close JL, Cote GM, Thaker PH, Ivy SP, Bose S, D'Andrea A, Marino-Enriquez A, Shapiro GI, Schwartz GK. Ingham M, et al. J Clin Oncol. 2023 Sep 1;41(25):4154-4163. doi: 10.1200/JCO.23.00402. Epub 2023 Jul 19. J Clin Oncol. 2023. PMID: 37467452
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?
Kasper B, D'Ambrosio L, Davis EJ, Ingham M, Broto JM, Trent JC, van Houdt WJ, Van Tine BA. Kasper B, et al. Among authors: ingham m. Curr Treat Options Oncol. 2022 Mar;23(3):439-449. doi: 10.1007/s11864-021-00928-y. Epub 2022 Mar 11. Curr Treat Options Oncol. 2022. PMID: 35275323 Free PMC article. Review.
Emerging Targeted and Immune-Based Therapies in Sarcoma.
Pollack SM, Ingham M, Spraker MB, Schwartz GK. Pollack SM, et al. Among authors: ingham m. J Clin Oncol. 2018 Jan 10;36(2):125-135. doi: 10.1200/JCO.2017.75.1610. Epub 2017 Dec 8. J Clin Oncol. 2018. PMID: 29220291 Review.
71 results